뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - pethidine hydrochloride 50 mg/ml; pethidine hydrochloride 50 mg/ml - solution for injection - 50 mg/ml - active: pethidine hydrochloride 50 mg/ml excipient: water for injection active: pethidine hydrochloride 50 mg/ml excipient: sodium hydroxide water for injection - dbl pethidine hydrochloride injection is indicated for administration as an anaesthetic adjunct and for obstetric analgesia. dbl pethidine hydrochloride injection is also indicated for the short-term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration – intramuscular (im), subcutaneous (sc), slow intravenous (iv) bolus injection, intravenous infusion and patient-controlled analgesia (pca).

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pethidine hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - dbl pethidine hydrochloride injection is indicated for the short-term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration: intramuscular, subcutaneous, slow intravenous bolus injection, intravenous infusion and patient controlled analgesia (pca).,dbl pethidine hydrochloride injection is also indicated for administration as an anaesthetic adjunct and for obstetric analgesia.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pethidine hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - dbl pethidine hydrochloride injection is indicated for the short-term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration: intramuscular, subcutaneous, slow intravenous bolus injection, intravenous infusion and patient controlled analgesia (pca).,dbl pethidine hydrochloride injection is also indicated for administration as an anaesthetic adjunct and for obstetric analgesia.

몰타 - 영어 - Medicines Authority

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - pethidine hydrochloride - solution for injection - pethidine hydrochloride 50 mg/ml - analgesics

몰타 - 영어 - Medicines Authority

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - pethidine hydrochloride - solution for injection - pethidine hydrochloride 50 mg/ml - analgesics

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - pethidine hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - indications as at 18 may 2020: 1. the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. 2. pre-operative medication. 3. analgesic adjunct in general anaesthesia. 4. obstetric analgesia.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - pethidine hydrochloride 100mg;   - tablet - 100 mg - active: pethidine hydrochloride 100mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - pethidine hydrochloride 50mg;   - tablet - 50 mg - active: pethidine hydrochloride 50mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water sodium starch glycolate

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - pethidine hydrochloride - solution for injection - 50 milligram(s)/millilitre - phenylpiperidine derivatives; pethidine

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - pethidine hydrochloride - solution for injection - 50 milligram(s)/millilitre - phenylpiperidine derivatives; pethidine